Molecular and Cellular Biochemistry

, Volume 378, Issue 1–2, pp 83–89 | Cite as

Rat brain myo-inositol 3-phosphate synthase is a phosphoprotein

  • R. N. Parthasarathy
  • J. Lakshmanan
  • M. Thangavel
  • R. S. Seelan
  • J. I. Stagner
  • A. J. Janckila
  • R. E. Vadnal
  • M. F. Casanova
  • L. K. Parthasarathy
Article

Abstract

The therapeutic effects of lithium in bipolar disorder are poorly understood. Lithium decreases free inositol levels by inhibiting inositol monophosphatase 1 and myo-inositol 3-phosphate synthase (IPS). In this study, we demonstrate for the first time that IPS can be phosphorylated. This was evident when purified rat IPS was dephosphorylated by lambda protein phosphatase and analyzed by phospho-specific ProQ-Diamond staining and Western blot analysis. These techniques demonstrated a mobility shift consistent with IPS being phosphorylated. Mass spectral analysis revealed that Serine-524 (S524), which resides in the hinge region derived from exon 11 of the gene, is the site for phosphorylation. Further, an antibody generated against a synthetic peptide of IPS containing monophosphorylated-S524, was able to discriminate the phosphorylated and non-phosphorylated forms of IPS. The phosphoprotein is found in the brain and testis, but not in the intestine. The intestinal IPS isoform lacks the peptide bearing S524, and hence, cannot be phosphorylated. Evidences suggest that IPS is monophosphorylated at S524 and that the removal of this phosphate does not alter its enzymatic activity. These observations suggest a novel function for IPS in brain and other tissues. Future studies should resolve the functional role of phospho-IPS in brain inositol signaling.

Keywords

Bipolar disorder Inositol phosphate synthase Myo-inositol Serine phosphorylation 

Supplementary material

11010_2013_1597_MOESM1_ESM.doc (22 kb)
Supplementary material 1 (DOC 22 kb)

References

  1. 1.
    Berridge MJ, Irvine RF (1989) Inositol phosphates and cell signaling. Nature 341:197–205PubMedCrossRefGoogle Scholar
  2. 2.
    Majerus PW, Kisseleva MV, Norris FA (1999) The role of phosphatases in inositol signaling reactions. J Biol Chem 274:10669–10672PubMedCrossRefGoogle Scholar
  3. 3.
    Parthasarathy R, Eisenberg F Jr (1986) The inositol phospholipids: a stereochemical view of biological activity. Biochem J 235:313–322PubMedGoogle Scholar
  4. 4.
    Fisher SK, Novak JE, Agranoff BW (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82:736–754PubMedCrossRefGoogle Scholar
  5. 5.
    Chakraborty A, Kim S, Snyder SH (2011) Inositol pyrophosphates as mammalian cell signals. Sci Signal 4:re1Google Scholar
  6. 6.
    Thurston JH, Sherman WR, Hauhart RE, Kloepper RF (1989) Myo-inositol: a newly identified non-nitrogenous osmoregulatory molecule in mammalian brain. Pediatr Res 26:482–485PubMedCrossRefGoogle Scholar
  7. 7.
    Eisenberg F Jr, Parthasarathy R (1987) Measurement of biosynthesis of myo-inositol from glucose 6-phosphate. Methods Enzymol 141:127–143PubMedCrossRefGoogle Scholar
  8. 8.
    Luo HR, Huang YE, Chen JC, Saiardi A, Iijima M, Ye K, Huang Y, Nagata E, Devreotes P, Snyder SH (2003) Inositol pyrophosphates mediate chemotaxis in Dictyostelium via pleckstrin homology domain-PtdIns(3,4,5)P3 interactions. Cell 114:559–572PubMedCrossRefGoogle Scholar
  9. 9.
    Saiardi A, Resnick AC, Snowman AM, Wendland B, Snyder SH (2005) Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinases. Proc Natl Acad Sci U S A 102:1911–1914Google Scholar
  10. 10.
    Monserrate JP, York JD (2010) Inositol phosphate synthesis and the nuclear processes they affect. Curr Opin Cell Biol 22:365–373PubMedCrossRefGoogle Scholar
  11. 11.
    Lee DW, Kim SY, Lee T, Nam YK, Ju A, Woo DC, You SJ, Han JS, Lee SH, Choi CB, Kim SS, Shin HC, Kim HY, Kim DJ, Rhim HS, Choe BY (2012) Ex vivo detection for chronic ethanol consumption-induced neurochemical changes in rats. Brain Res 1429:134–144PubMedCrossRefGoogle Scholar
  12. 12.
    Minati L, Aquino D, Bruzzone MG, Erbetta A (2010) Quantitation of normal metabolite concentrations in six brain regions by in vivo H-MR spectroscopy. J Med Phys 35:154–163PubMedCrossRefGoogle Scholar
  13. 13.
    Parthasarathy L, Vadnal RE, Parthasarathy R, Devi CS (1994) Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase. Life Sci 54:1127–1142PubMedCrossRefGoogle Scholar
  14. 14.
    Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, Belmaker RH (1995) Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 152:792–794PubMedGoogle Scholar
  15. 15.
    Vadnal RE, Parthasarathy L, Parthasarathy R (1997) Role of inositol in psychiatric disorders: basic and clinical aspects. CNS Drugs 7:6–16CrossRefGoogle Scholar
  16. 16.
    Vadnal RE, Parthasarathy L, Parthasarathy R (1998) Promising psychotherapeutic effects of the natural sugar: myo-inositol. Nutr Neurosci 1:21–33Google Scholar
  17. 17.
    Agam G, Shamir A, Shaltiel G, Greenberg ML (2002) Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs. Bipolar Disord 4(Suppl s1):15–20Google Scholar
  18. 18.
    Seelan RS, Lakshmanan J, Casanova MF, Parthasarathy RN (2009) Identification of myo-inositol-3-phosphate synthase isoforms: characterization, expression, and putative role of a 16-kDa γc isoform. J Biol Chem 284:9443–9457PubMedCrossRefGoogle Scholar
  19. 19.
    Zhuo S, Clemens JC, Hakes DJ, Barford D, Dixon JE (1993) Expression, purification, crystallization and biochemical characterization of a recombinant protein phosphatase. J Biol Chem 268:17754–17761PubMedGoogle Scholar
  20. 20.
    Lahm HW, Langen H (2000) Mass spectrometry: a tool for the identification of proteins separated by gels. Electrophoresis 21:2105–2114PubMedCrossRefGoogle Scholar
  21. 21.
    Imanishi SY, Kochin V, Ferraris SE, de Thonel A, Pallari HM, Corthals GL, Eriksson JE (2007) Reference-facilitated phosphoproteomics: fast and reliable phosphopeptide validation by micro LC-ESI-Q-TOF MS/MS. Mol Cell Proteomics 6:1380–1391Google Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2013

Authors and Affiliations

  • R. N. Parthasarathy
    • 1
    • 2
    • 3
  • J. Lakshmanan
    • 1
    • 3
    • 4
  • M. Thangavel
    • 1
    • 3
  • R. S. Seelan
    • 1
    • 3
    • 5
  • J. I. Stagner
    • 6
  • A. J. Janckila
    • 7
    • 8
  • R. E. Vadnal
    • 9
  • M. F. Casanova
    • 1
  • L. K. Parthasarathy
    • 1
    • 3
  1. 1.Molecular Neuroscience and Bioinformatics Laboratories, Mental Health, Behavioral Science and Research ServicesRobley Rex Veterans Affairs Medical CenterLouisvilleUSA
  2. 2.Department of Biochemistry and Molecular BiologyUniversity of LouisvilleLouisvilleUSA
  3. 3.Department of Psychiatry and Behavioral SciencesUniversity of LouisvilleLouisvilleUSA
  4. 4.Price Institute of Surgical Research, Department of Surgery, School of MedicineUniversity of LouisvilleLouisvilleUSA
  5. 5.Department of Molecular, Cellular & Craniofacial Biology, School of DentistryUniversity of LouisvilleLouisvilleUSA
  6. 6.Research ServicesRobley Rex Veterans Affairs Medical CenterLouisvilleUSA
  7. 7.Special Hematology LabRobley Rex Veterans Affairs Medical CenterLouisvilleUSA
  8. 8.Department of Microbiology and Immunology, School of MedicineUniversity of LouisvilleLouisvilleUSA
  9. 9.Eastern Colorado Health Care SystemDepartment of Veterans AffairsPuebloUSA

Personalised recommendations